story of the week
Real-World Effectiveness of Palbociclib Plus Endocrine Therapy in HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial
Oncologist 2024 Oct 30;[EPub Ahead of Print], D Tripathy, JL Blum, MS Karuturi, S McCune, S Kurian, M Moezi, D Anderson, E Gauthier, Z Zhang, MZ Montelongo, Y Wang, GB RocqueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.